+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tramadol"

From
Opioids Market Report 2025 - Product Thumbnail Image

Opioids Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Peripheral Neuropathic Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Peripheral Neuropathic Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
Opioid Drugs: Global Markets to 2023 - Product Thumbnail Image

Opioid Drugs: Global Markets to 2023

  • Report
  • November 2018
  • 147 Pages
  • Global
From
From
From
Loading Indicator

Tramadol is an opioid analgesic used to treat moderate to severe pain. It is a centrally acting synthetic opioid analgesic, similar to codeine, and is available in both immediate-release and extended-release formulations. Tramadol is used to treat a variety of conditions, including chronic pain, post-operative pain, and pain associated with cancer. It is also used to treat neuropathic pain, fibromyalgia, and other conditions. Tramadol is generally well-tolerated, but can cause side effects such as nausea, dizziness, and constipation. The analgesic market is highly competitive, with a variety of products available. Tramadol is one of the most commonly prescribed analgesics, and is available in both generic and branded formulations. It is available in both oral and injectable forms, and is often used in combination with other analgesics. Some companies in the Tramadol market include Mylan, Teva Pharmaceuticals, and Actavis. Show Less Read more